Table 10 The targeted genes identified by the common drugs derived from both two methods (the parentheses represent the number of associated cMap drugs)
Early-stage NSCLC | |||
 ADRB2 (4) | CASP1 (3) | KAT2A (2) | SNCA (1) |
 ARRB1(1) | PSIP1 (1) | PAFAH1B3 (1) | GAPDH (1) |
Late-stage NSCLC | |||
 ADRB2 (6) | ARRB1 (3) | NCOA1 (3) | PSIP1 (3) |
 SMARCA2 (3) | GAPDH (3) | CPT1A (1) | AURKB (1) |
 IRAK1 (1) | GRK5 (1) | SRPK1 (1) | AURKA (1) |